2/27
School of Engineering & Applied Science
Getting to the root of root canals
Getting to the root of root canals
Penn researchers use iron oxide nanozymes to treat infections during root canals with fewer adverse effects than clinical gold standard while also promoting tissue healing.
Stentix wins the 2025 Y-Prize
Stentix wins the 2025 Y-Prize
The winning team of Penn Engineering’s annual award for entrepreneurial technology have created a noninvasive mechanism to adjust medical stent positioning using magnetic reconfiguration.
Four from Penn named 2025 Sloan Research Fellows
Four from Penn named 2025 Sloan Research Fellows
Jason Altschuler, César de la Fuente, Liang Wu, and Anderson Ye Zhang have been honored as early-career researchers and scholars for their accomplishments, creativity, and potential to become leaders in their fields.
Pursuing vaccines to stop celiac disease
Pursuing vaccines to stop celiac disease
Scientists at Penn’s Institute for RNA Innovation are using messenger RNA to stop the immune response that triggers celiac disease symptoms.
Is Moore’s Law really dead?
Is Moore’s Law really dead?
Penn Engineering’s Ben Lee and André DeHon discuss Moore’s Law, the observation that the number of transistors on an integrated circuit will double every two years with minimal rise in cost, and reflect on the consequences and opportunities of its possible end.
Quantum communications
Quantum communications
Penn and CUNY researchers collaborated to develop a device that uses quantum principles to relay information securely—an advance that could improve encryption in critical service areas like banking and health care.
Borrowing nature’s blueprint: How scientists replicated bone marrow
Borrowing nature’s blueprint: How scientists replicated bone marrow
A collaborative research team from Penn Engineering, Penn Medicine, and the Children’s Hospital of Philadelphia have developed a chip that mimics human bone marrow.
BEND lipids improve LNP mRNA delivery and gene editing
BEND lipids improve LNP mRNA delivery and gene editing
Penn Engineering researchers have developed a new class of lipids called branched endosomal disruptor (BEND) lipids to better deliver mRNA and gene-editing tools.
Who to vaccinate first? Answering a life-or-death question with network theory
Who to vaccinate first? Answering a life-or-death question with network theory
Researchers from Penn Engineering and Penn Medicine have collaborated to determine the best theoretical strategy for a vaccine rollout.
Beth A. Winkelstein reappointed as deputy provost
Beth A. Winkelstein reappointed as deputy provost
Winkelstein has taught at Penn for more than twenty years as a leader of interdisciplinary research, and has served as deputy provost since 2020.
In the News
CNN
What officials are doing—and suggesting—to learn more about the possible drone sightings
Dean Vijay Kumar of the School of Engineering and Applied Science says that the main difficulties in detecting and tracking drones stem from their small size, agility, and potential for autonomous operation.
FULL STORY →
CNN
Why you shouldn’t try to shoot down a suspected drone
Dean Vijay Kumar of the School of Engineering and Applied Science says that shooting at potential drones could lead to missed shots, stray bullets, or accidents that result in hazardous outcomes far beyond the intended action.
FULL STORY →
HealthDay
In mouse studies, new hope against a dangerous complication of pregnancy
Doctoral student Kelsey Swingle in the School of Engineering and Applied Science and colleagues are using mRNA molecules to treat pre-eclampsia, a common pregnancy complication.
FULL STORY →
Newsweek
What New Jersey’s mystery drones could actually be, according to experts
Dean Vijay Kumar of the School of Engineering and Applied believes that mystery drones in New Jersey are part a U.S. government operation rather than being sent by a foreign state actor.
FULL STORY →
New Scientist
Pre-eclampsia could be treated with mRNA technology
Michael Mitchell and Ph.D. student Kelsey Swingle of the School of Engineering and Applied Science and colleagues are using mRNA molecules to treat pre-eclampsia, a common pregnancy complication.
FULL STORY →